The Big Trial of a GLP-1 drug (Wegovy) to Reduce Major Cardiovascular Events Presented at the American Heart Association and simultaneously published in NEJM today is the trial of over 17,600 patients who were randomly assigned either the GLP-1 semaglutide (a glucagon-like peptide-1 receptor agonist) or placebo and were followed for well over 3 years
The trade-off is bundle pricing thats more predictable up front and an offering that covers substantially more of the mens optimization stack than any GLP-1-only program
The benefits of Vitamin D include the following: Vitamin D can help your body absorb calcium, leading to stronger bones Vitamin D can help regulate insulin in the body, aiding patients in the management of diabetes Vitamin D is important to the overall health of the immune system Vitamin D can help keep your brain and nervous system healthy Vitamin D can help you regulate or improve your overall mood Vitamin D can help support strong lungs and your cardiovascular system There are, of course, more benefits to Vitamin D, especially in terms of the way your skin looks and how you feel
Beyond the Scale Heart Health: Semaglutide lowered risk of heart attack, stroke, and cardiovascular death by ~20% in people with obesity and heart disease, even without diabetes
Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy